NCT07496372: A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)
- State
- Under way
- Phase
- Phase 3
- People
- 80 planned
- Started
- 30 Apr 2026
- Primary completion
- 30 Jun 2027
- Arms
- Experimental group
- Results
- None posted
- 27 Mar 2026: Trial registered